StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.40−0.02 (-1.41%)

Close on Nov 12, 2026Market cap $73.47MP/E –Yield –

OKYO Pharma statistics

50 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Mar 31, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$73.47M
$272.32M
Enterprise Value
$58.88M
$146.23M

Share statisticsIndustry

Float
31M
49M
Shares Held by Insiders
41.2%
11.7%
Shares Held by Institutions
12.4%
56.4%

Short sellingIndustry

Short Interest
45,609
–
Short Interest Change
-40.5%
-0.80%
Short % of Float
0.15%
9.01%
Short % of Shares Outstanding
0.09%
6.30%
Days to Cover
1.00
5.15

Stock price statisticsIndustry

52-Week High
$3.20
–
52-Week Low
$1.26
–
20-Day Moving Average
$1.43
–
50-Day Moving Average
$1.42
–
200-Day Moving Average
$1.58
–
Average True Range (14)
$0.11
–
Price Change (1 Week)
0.00%
-1.15%
Price Change (1 Month)
-1.06%
-4.87%
Price Change (3 Months)
-7.89%
-21.0%
Price Change (6 Months)
-13.0%
-20.6%
Price Change (YTD)
-32.4%
-23.6%
Price Change (1 Year)
-49.3%
-22.4%
Price Change (3 Years)
-17.6%
-29.5%
Average Volume (10 Days)
86,985
–
Average Volume (20 Days)
68,455
–
Average Volume (90 Days)
85,889
–
Relative Volume
1.29
0.70
Relative Strength Index (14)
48.0
43.4
Volatility (1 Year)
72.9%
80.1%
Beta (5 Years)
0.32
1.07

Financial positionIndustry

Current Ratio
2.43
3.30
Quick Ratio
1.69
2.39

EfficiencyIndustry

Employee Count
5
74
WACC
7.60%
10.2%

Income statement (TTM)Industry

Pretax Income
-$8.94M
-$12.95M
EBITDA
-$8.47M
-$17.21M
EPS (Diluted)
-$0.24
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$14.59M
$17.76M
Net Cash Per Share
$0.28
$0.80
Working Capital
$12.33M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$5.94M
-$12.38M
Capital Expenditures
-$6.08K
-$1.00M
Free Cash Flow
-$5.94M
-$18.21M
FCF Per Share
-$0.11
-$0.42

Dividends and yieldsIndustry

FCF Yield
-8.09%
-9.44%

Taxes and interestIndustry

Interest Expense
$474.22K
$2.90M
Income Tax
-$7.99K
$73.00K

Scores and fair valueIndustry

Altman Z-Score
-4.34
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodOKYOS&P 500DifferenceOKYO per yearS&P 500 per year
1 month-2.8%-2.7%−0.1 pts
3 months-7.0%-1.7%−5.2 pts
Year to date-32.4%+11.9%−44.3 pts
1 year-46.2%+12.0%−58.1 pts
3 years-18.6%+78.2%−96.8 pts-6.6%+21.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M OKYO shares were sold short on Oct 30, 2026, down 40.5% from the previous report, or 0.15% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 28.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202645,609-40.5%54,9101.0
Oct 15, 202676,652+121.3%42,9291.8
Sep 30, 202634,643-17.8%76,3161.0
Sep 15, 202642,141-22.3%91,7851.0
Aug 31, 202654,269-35.0%64,1331.0
Aug 14, 202683,450-38.4%69,3821.2
Jul 31, 2026135,370+223.4%144,7001.0
Jul 15, 202641,862+29.3%189,0491.0
Jun 30, 202632,380-60.9%64,9161.0
Jun 15, 202682,735-33.5%62,8501.3
May 29, 2026124,433-23.5%48,5272.6
May 15, 2026162,711-38.3%51,3013.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?